TearLab Corp Uncategorized Contracts & Agreements
77 Contracts & Agreements
- Consent dated March 31, 2020 (Filed With SEC on June 26, 2020)
- TEARLAB CORPORATION (Filed With SEC on May 29, 2020)
- TEARLAB CORPORATION (Filed With SEC on May 11, 2020)
- Description of Securities (Filed With SEC on March 6, 2020)
- ********************* (Filed With SEC on November 13, 2017)
- ********************* (Filed With SEC on August 21, 2017)
- MUTUALTERMINATION OF AMENDED AND RESTATED COOPERATIVE MARKETINGAGREEMENT (Filed With SEC on August 14, 2017)
- CONFIDENTIALTREATMENT REQUESTED (Filed With SEC on March 10, 2017)
- CONFIDENTIALTREATMENT REQUESTED (Filed With SEC on May 9, 2016)
- SECURITIESPURCHASE AGREEMENT (Filed With SEC on April 29, 2016)
- Year (Filed With SEC on December 29, 2011)
- TEARLAB CORPORATION (Filed With SEC on July 1, 2011)
- Form of Director and Affiliate Letter Agreement (Filed With SEC on July 16, 2009)
- Second Amending Agreement, dated as of October 6, 2008, by and among OccuLogix, Inc., OcuSense Acquireco, Inc. and OcuSense, Inc (Filed With SEC on October 9, 2008)
- Amending Agreement, dated as of July 28, 2008, by and among OccuLogix, Inc., OcuSense Acquireco, Inc. and OcuSense, Inc (Filed With SEC on July 28, 2008)
- Amending Agreement by and among OccuLogix, Inc., Marchant Securities Inc. and the investor party thereto (Filed With SEC on July 28, 2008)
- Letter Agreement, dated December 20, 2007, between the Registrant and Solx Acquisition, Inc (Filed With SEC on March 17, 2008)
- Research Agreement, dated as of December 13, 2007, between * and OcuSense, Inc. (Portions of this exhibit have been omitted pursuant to a request for confidential treatment.) (Filed With SEC on March 17, 2008)
- Terms of Business, dated February 5, 2007, between Invetech Pty Ltd and OcuSense, Inc (Filed With SEC on March 17, 2008)
- $8,000,000 STANDBY COMMITMENT SUMMARY OF TERMS AND CONDITIONS (Filed With SEC on March 15, 2007)
- 2006 DISTRIBUTORSHIP AGREEMENT (Filed With SEC on November 9, 2006)
- AMENDING AGREEMENT (Filed With SEC on May 10, 2006)
- AMENDING AGREEMENT (Filed With SEC on May 10, 2006)
- AMENDING AGREEMENT (Filed With SEC on May 10, 2006)
- 2005 Memorandum between Asahi Kasei Medical Co., Ltd. and the Registrant dated October 17, 2005 (Filed With SEC on March 16, 2006)
- Option Agreement between Steve Parks and the Registrant dated as of October 4, 2005 (Filed With SEC on November 10, 2005)
- Addresses a large AMD patient population with limited current treatment options. Current Wet AMD treatments are effective only on patients who are newly-diagnosed with Wet AMD, of... (Filed With SEC on December 8, 2004)
- Addresses a large AMD patient population with limited current treatment options. Current Wet AMD treatments are effective only on patients who are newly-diagnosed with Wet AMD, of... (Filed With SEC on December 8, 2004)
- Addresses a large AMD patient population with limited current treatment options. Current Wet AMD treatments are effective only on patients who are newly-diagnosed with Wet AMD, of... (Filed With SEC on December 6, 2004)
- Addresses a large AMD patient population with limited current treatment options. Current Wet AMD treatments are effective only on patients who are newly-diagnosed with Wet AMD, of... (Filed With SEC on December 6, 2004)
- Addresses a large AMD patient population with limited current treatment options. Current Wet AMD treatments are effective only on patients who are newly-diagnosed with Wet AMD, of... (Filed With SEC on December 6, 2004)
- Addresses a large AMD patient population with limited current treatment options. Current Wet AMD treatments are effective only on patients who are newly-diagnosed with Wet AMD, of... (Filed With SEC on December 6, 2004)
- Addresses a large AMD patient population with limited current treatment options. Current Wet AMD treatments are effective only on patients who are newly-diagnosed with Wet AMD, of... (Filed With SEC on December 6, 2004)
- Addresses a large AMD patient population with limited current treatment options. Current Wet AMD treatments are effective only on patients who are newly-diagnosed with Wet AMD, of... (Filed With SEC on December 6, 2004)
- Addresses a large AMD patient population with limited current treatment options. Current Wet AMD treatments are effective only on patients who are newly-diagnosed with Wet AMD, of... (Filed With SEC on December 6, 2004)
- Addresses a large AMD patient population with limited current treatment options. Current Wet AMD treatments are effective only on patients who are newly-diagnosed with Wet AMD, of... (Filed With SEC on December 6, 2004)
- Addresses a large AMD patient population with limited current treatment options. Current Wet AMD treatments are effective only on patients who are newly-diagnosed with Wet AMD, of... (Filed With SEC on November 16, 2004)
- Addresses a large AMD patient population with limited current treatment options. Current Wet AMD treatments are effective only on patients who are newly-diagnosed with Wet AMD, of... (Filed With SEC on November 16, 2004)
- Addresses a large AMD patient population with limited current treatment options. Current Wet AMD treatments are effective only on patients who are newly-diagnosed with Wet AMD, of... (Filed With SEC on November 16, 2004)
- Addresses a large AMD patient population with limited current treatment options. Current Wet AMD treatments are effective only on patients who are newly-diagnosed with Wet AMD, of... (Filed With SEC on November 16, 2004)
